1 |
Bajic, G., Yatime, L., Sim, R.B., Vorup-Jensen, T., and Andersen, G.R. (2013). Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc. Natl. Acad. Sci. U. S. A. 110, 16426-16431.
DOI
|
2 |
Becherer, J.D., Alsenz, J., Esparza, I., Hack, C.E., and Lambris, J.D. (1992). Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B. Biochemistry 31, 1787-1794.
DOI
|
3 |
Carroll, M.C. (2004). The complement system in regulation of adaptive immunity. Nat. Immunol. 5, 981-986.
DOI
|
4 |
Choi, J., Choi, J., and Nham, S.U. (2010). Characterization of the residues of αX I-domain and ICAM-1 mediating their interactions. Mol. Cells 30, 227-234.
DOI
|
5 |
Diamond, M.S., Garcia-Aguilar, J., Bickford, J.K., Corbi, A.L., and Springer, T.A. (1993). The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120, 1031-1043.
DOI
|
6 |
Gaither, T.A., Vargas, I., Inada, S., and Frank, M.M. (1987). The complement fragment C3d facilitates phagocytosis by monocytes. Immunology 62, 405-411.
|
7 |
Gang, J., Choi, J., Lee, J.H., and Nham, S.U. (2007). Identification of critical residues for plasminogen binding by the αX I-domain of the β2 integrin, αXβ2. Mol. Cells 24, 240-246.
|
8 |
Gros, P., Milder, F.J., and Janssen, B.J. (2008). Complement driven by conformational changes. Nat. Rev. Immunol. 8, 48-58.
DOI
|
9 |
Helmy, K.Y., Katschke, K.J., Gorgani, N.N., Kljavin, N.M., Elliott, J.M., Diehl, L., Scales, S.J., Ghilardi, N., and van Lookeren Campagne, M. (2006). CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915-927.
DOI
|
10 |
Michishita, M., Videm, V., and Arnaout, M.A. (1993). A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 72, 857-867.
DOI
|
11 |
Inada, S., Brown, E.J., Gaither, T.A., Hammer, C.H., Takahashi, T., and Frank, M.M. (1983). C3d receptors are expressed on human monocytes after in vitro cultivation. Proc. Natl. Acad. Sci. U. S. A. 80, 2351-2355.
DOI
|
12 |
Janssen, B.J. and Gros, P. (2007). Structural insights into the central complement component C3. Mol. Immunol. 44, 3-10.
DOI
|
13 |
Janssen, B.J., Huizinga, E.G., Raaijmakers, H.C., Roos, A., Daha, M.R., Nilsson-Ekdahl, K., Nilsson, B., and Gros, P. (2005). Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511.
DOI
|
14 |
Lee, J.H., Choi, J., and Nham, S.U. (2007). Critical residues of αX I-domain recognizing fibrinogen central domain. Biochem. Biophys. Res. Commun. 355, 1058-1063.
DOI
|
15 |
Lee, J.O., Rieu, P., Arnaout, M.A., and Liddington, R. (1995). Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 80, 631-638.
DOI
|
16 |
Luo, B.H., Carman, C.V., and Springer, T.A. (2007). Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619-647.
DOI
|
17 |
Plow, E.F., Haas, T.A., Zhang, L., Loftus, J., and Smith, J.W. (2000). Ligand binding to integrins. J. Biol. Chem. 275, 21785-21788.
DOI
|
18 |
Myones, B.L., Dalzell, J.G., Hogg, N., and Ross, G.D. (1988). Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J. Clin. Invest. 82, 640-651.
DOI
|
19 |
Papanastasiou, P., Koutsogiannaki, S., Sarigiannis, Y., Geisbrecht, B.V., Ricklin, D., and Lambris, J.D. (2017). Structural implications for the formation and function of the complement effector protein iC3b. J. Immunol. 198, 3326-3335.
DOI
|
20 |
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.
DOI
|
21 |
Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J.D. (2010). Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785-797.
DOI
|
22 |
Ross, G.D. and Medof, M.E. (1985). Membrane complement receptors specific for bound fragments of C3. Adv. Immunol. 37, 217-267.
DOI
|
23 |
Taniguchi-Sidle, A. and Isenman, D.E. (1992). Mutagenesis of the ArgGly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). J. Biol. Chem. 267, 635-643.
DOI
|
24 |
Taniguchi-Sidle, A. and Isenman, D.E. (1994). Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 α'-chain. J. Immunol. 153, 5285-5302.
|
25 |
Vorup-Jensen, T., Ostermeier, C., Shimaoka, M., Hommel, U., and Springer, T.A. (2003). Structure and allosteric regulation of the αXβ2 integrin I domain. Proc. Natl. Acad. Sci. U. S. A. 100, 1873-1878.
DOI
|
26 |
Arnaout, M.A., Mahalingam, B., and Xiong, J.P. (2005). Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381-410.
DOI
|
27 |
Ueda, T., Rieu, P., Brayer, J., and Arnaout, M.A. (1994). Identification of the complement iC3b binding site in the β2 integrin CR3 (CD11b/CD18). Proc. Natl. Acad. Sci. U. S. A. 91, 10680-10684.
DOI
|
28 |
Ustinov, V.A. and Plow, E.F. (2005). Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin αMβ2. Biochemistry 44, 4357-4364.
DOI
|
29 |
Vorup-Jensen, T., Carman, C.V., Shimaoka, M., Schuck, P., Svitel, J., and Springer, T.A. (2005). Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin αXβ2. Proc. Natl. Acad. Sci. U. S. A. 102, 1614-1619.
DOI
|
30 |
Vorup-Jensen, T. and Jensen, R.K. (2018). Structural immunology of complement receptors 3 and 4. Front. Immunol. 9, 1-20.
DOI
|
31 |
Xu, S., Wang, J., Wang, J.H., and Springer, T.A. (2017). Distinct recognition of complement iC3b by integrins αXβ2 and αMβ2. Proc. Natl. Acad. Sci. U. S. A. 114, 3403-3408.
DOI
|